Clinical Trials Logo

Surgery clinical trials

View clinical trials related to Surgery.

Filter by:
  • No longer available  
  • Page 1

NCT ID: NCT01701947 No longer available - Surgery Clinical Trials

HEMOLEVEN® Expanded Access Program Prevention of Surgical/Postpartum Hemorrhage Severe Inherited Factor XI Deficiency

Start date: n/a
Phase: N/A
Study type: Expanded Access

The objective of the Expanded Access Program is to provide HEMOLEVEN, a replacement coagulation factor XI, to patients with severe inherited factor XI deficiency where, in the opinion of the treating physician, the benefits of administering selectively the missing factor outweigh the potential risks associated with the administration of fresh-frozen plasma.